The stock of CVR MEDICAL CORP (CVE:CVM) is a huge mover today! About 30,450 shares traded hands or 54.47% up from the average. CVR MEDICAL CORP (CVE:CVM) has risen 6.00% since September 17, 2016 and is uptrending. It has outperformed by 0.39% the S&P500.
The move comes after 6 months positive chart setup for the $15.54 million company. It was reported on Oct, 17 by Barchart.com. We have $1.36 PT which if reached, will make CVE:CVM worth $30.46M more.
More notable recent CVR MEDICAL CORP (CVE:CVM) news were published by: Marketwatch.com which released: “CVR Medical Corp.” on September 30, 2016, also Finance.Yahoo.com with their article: “CVR Medical Retains Market Making Services” published on October 12, 2016, Marketwatch.com published: “CVR Medical Retains Brisco Capital Investor Relations” on September 30, 2016. More interesting news about CVR MEDICAL CORP (CVE:CVM) were released by: Stockhouse.com and their article: “IIROC Trade Resumption – CVR Medical Corp.” published on June 11, 2012 as well as Stockhouse.com‘s news article titled: “CVR Medical Provides Corporate Update After Trading Resumption” with publication date: October 13, 2016.
CVM Company Profile
CEL-SCI Corporation, incorporated on March 22, 1983, is a biotechnology company. The Firm is engaged in the research and development of drugs and vaccines. The Firm researches and develops immunotherapy products for the treatment of cancer and infectious diseases. The Company’s product pipeline consists of Multikine (Leukocyte Interleukin, Injection) investigational immunotherapy against cancer and Human Papilloma Virus (HPV), and Ligand Epitope Antigen Presentation System (LEAPS) technology, with two investigational therapies, LEAPS-H1N1-DC pandemic flu treatment for hospitalized patients, and CEL-2000, a rheumatoid arthritis treatment vaccine.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.